Literature DB >> 23235808

[A case report of transfusion-transmitted Plasmodium vivax malaria from an asymptomatic donor to a premature newborn].

Daniel Echeverri1, Dhayra Karem Barreto, Lyda Osorio, Armando Cortés, Ernesto Martínez.   

Abstract

Most of the Colombian territory is endemic for malaria. Autochthonous cases with low parasitemia occur in the Pacific coast and in large zones of Antioquia and Córdoba. According to the Colombian legislation no malaria screening test is mandatory for blood donors from non-endemic areas. However, if they have traveled to malaria transmission regions they are deferred for six months before they can donate. This report describes a transfusion- transmitted malaria case in Cali (Valle del Cauca, Colombia), where a preterm newborn received infected blood from a donor that lived in the same city, but he had traveled to the rural area of the municipality of Dagua (Valle del Cauca, Colombia) 9 months before the donation. Thick blood smears confirmed Plasmodium vivax infection in the newborn and the donor sample was analyzed by PCR, which confirmed P. vivax infection. This case suggests the need for reviewing donor selection criteria and deferral strategies to prevent possible cases of transfusion-transmitted malaria.

Entities:  

Mesh:

Year:  2012        PMID: 23235808     DOI: 10.1590/S0120-41572012000500002

Source DB:  PubMed          Journal:  Biomedica        ISSN: 0120-4157            Impact factor:   0.935


  3 in total

1.  Malaysian child infected with Plasmodium vivax via blood transfusion: a case report.

Authors:  Claudia N Anthony; Yee-Ling Lau; Jia-Siang Sum; Mun-Yik Fong; Hany Ariffin; Wai-Linn Zaw; Indra Jeyajothi; Rohela Mahmud
Journal:  Malar J       Date:  2013-09-04       Impact factor: 2.979

2.  A systematic review of transfusion-transmitted malaria in non-endemic areas.

Authors:  Federica Verra; Andrea Angheben; Elisa Martello; Giovanni Giorli; Francesca Perandin; Zeno Bisoffi
Journal:  Malar J       Date:  2018-01-16       Impact factor: 2.979

3. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2022-04       Impact factor: 1.513

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.